Clinical significance of poor CD3 response in head and neck cancer

Clinical Cancer Research

Volumn 8, Issue 3, 2002, Pages 745-751

  Shibuya, Terry Y ^a   Nugyen, Nghia ^a   McLaren, Christine E ^a   Li, Kuo Tung ^a   Wei, Wei Zen ^a   Kim, Sanghun ^a   Yoo, George H ^a   Rogowski, Amy ^a   Ensley, John ^a   Sakr, Wael ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CD3 ANTIGEN; MONOCLONAL ANTIBODY CD3; T LYMPHOCYTE RECEPTOR; THYMIDINE; TRITIUM;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; HEAD AND NECK CANCER; HUMAN; INCIDENCE; LENGTH OF STAY; LYMPH NODE; LYMPHOCYTE SUBPOPULATION; MALE; MONONUCLEAR CELL; PHENOTYPE; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; TREATMENT OUTCOME;

EID: 0036307836     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Immunotherapy of squamous cell carcinoma of the head and neck
2. lck in T-cells infiltrating human renal cell carcinoma
3. Alteration in expression and function of signal transducing proteins in tumor associated T and NK cells in patients with ovarian carcinoma
4. Alterations in T-cell receptor and signal transduction molecules in melanoma patients
5. Alterations in the signal transducing molecules of T cells and NK cells in colorectal tumor infiltrating gut mucosal and peripheral lymphocytes: Correlation with the stage of the disease
6. T cells infiltrating non-Hodgkin's B-cell lymphomas show altered tyrosine phosphorylation pattern even though T cell receptor/CD3-associated kinases are present
7. Anti-CD3/anti-CD28 bead stimulation overcomes CD3 unresponsiveness in patients with head and neck squamous cell carcinoma
8. Antiviral effect and ex vivo CD4+ T-cell proliferation in HIV positive patients as a result of CD28 costimulation
9. Lymphocyte apoptosis induced by Fas ligand-expressing ovarian carcinoma cells
10. Signaling defects in T lymphocytes of patients with malignancy
11. Alterations in signal transduction molecules in T lymphocytes from tumor-bearing mice
12. Decreased expression of the signal-transducing ζ chains in tumor-infiltrating T-cells and NK cells of patients with colorectal carcinoma
13. T-cell receptor ζ-chain expression on tumor-infiltrating lymphocytes from renal cell carcinoma
14. Absent or low expression of the ζ chain in T cells at the tumor site correlates with poor survival in patients with oral carcinoma
15. Mechanisms responsible for signaling and functional defects
16. Clinical significance of decreased ζ chain expression in peripheral blood lymphocytes of patients with head and neck cancer
17. Peripheral blood mononuclear cell responsiveness in patients with head and neck cancer in relation to tumor stage and prognosis
18. Peripheral blood T-lymphocyte and monocyte function and survival in patients with head and neck carcinoma
19. Fas ligand is expressed on human squamous cell carcinoma of the head and neck, and it promotes apoptosis of T lymphocytes
20. Spontaneous ex vivo apoptosis of peripheral blood mononuclear cells in patients with head and neck cancer
21. 2 production by squamous cell carcinoma of the head and neck
22. Comparison of retroviral pl5E-related factors and interferon α in head and neck cancer
23. Role of fas ligand (CD95L) in immune escape: The tumor cell strikes back